关节镜肩手术锁骨后臂丛阻滞0.5%罗哌卡因最佳容量的I/II期试验
I期确定最大耐受容量为35 ml(膈肌麻痹率0.09,95%可信区间0–0.29);II期确定最佳生物学容量为25 ml,阻滞成功率1.0(95%可信区间0.95–1.0),膈肌麻痹率0.01(95%可信区间0–0.06)。
要点
- 单次锁骨后臂丛阻滞0.5%罗哌卡因最大耐受容量为35 ml,膈肌麻痹率0.09。
- 最佳生物学容量为25 ml,阻滞成功率1.0,膈肌麻痹率0.01。
- 结论支持25 ml用于关节镜肩手术,但需进一步研究确认。
核心结论
- 单次锁骨后臂丛阻滞使用25 ml 0.5%罗哌卡因可获得一致阻滞成功且膈肌麻痹率极低。
研究设计与样本
- 无缝单臂探索性I/II期试验,采用贝叶斯最优区间设计指导容量递增确定最大耐受容量,随后用贝叶斯最优II期设计序贯扩展确定最佳生物学容量。
主要发现
- I期主要结局为阻滞完成后30 min超声测量的完全或部分膈肌麻痹。
- II期主要结局为阻滞成功,定义为总感觉运动评分≥12分且总感觉评分≥3分,通过手动感觉运动测试测量。
- 最大耐受容量为35 ml 0.5%罗哌卡因,膈肌麻痹率0.09(95%可信区间0–0.29)。
- 最佳生物学容量为25 ml,阻滞成功率1.0(95%可信区间0.95–1.0),膈肌麻痹率0.01(95%可信区间0–0.06)。
关键数值与推荐
- 最大耐受容量:35 ml 0.5%罗哌卡因,膈肌麻痹率0.09(95%可信区间0–0.29)。
- 最佳生物学容量:25 ml 0.5%罗哌卡因,阻滞成功率1.0(95%可信区间0.95–1.0),膈肌麻痹率0.01(95%可信区间0–0.06)。
临床怎么用
- 关节镜肩手术行单次锁骨后臂丛阻滞时,可考虑使用25 ml 0.5%罗哌卡因以兼顾阻滞成功与低膈肌麻痹风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A brachial plexus block plays an important role in providing perioperative analgesia for shoulder surgery; however, the inherent risk of phrenic nerve block and resulting hemidiaphragmatic paralysis may limit its use in patients with compromised pulmonary function. This study aimed to evaluate the safety, efficacy, maximum tolerated volume, and optimal biologic volume of 0.5% ropivacaine used in a single-injection retroclavicular brachial plexus block for arthroscopic shoulder surgery. METHODS: In this seamless single-arm exploratory phase I/II trial, a novel Bayesian optimal interval design was used to guide volume escalation for determination of the maximum tolerated volume, followed by sequential volume expansion using Bayesian optimal phase 2 design to establish the optimal biologic volume. Fifty-four patients who underwent arthroscopic shoulder surgery received a single-injection retroclavicular brachial plexus block with 0.5% ropivacaine ranging from 15 to 40 ml. The primary outcomes were complete or partial hemidiaphragmatic paralysis in phase I, measured using ultrasound 30 min after block completion, and the block success in phase II, defined as achieving a total sensorimotor score 12 points or greater and the total sensory score 3 points or greater, measured through manual sensorimotor testing. RESULTS: The maximum tolerated volume for the single-injection retroclavicular brachial plexus block was determined to be 35 ml of 0.5% ropivacaine, with a hemidiaphragmatic paralysis rate of 0.09 (95% credible interval, 0 to 0.29). The optimal biologic volume was found to be 25 ml, with a block success rate of 1.0 (95% credible interval, 0.95 to 1.0) and a negligible hemidiaphragmatic paralysis rate of 0.01 (95% credible interval, 0 to 0.06). CONCLUSIONS: A single-injection retroclavicular brachial plexus block using 25 ml of 0.5% ropivacaine produced consistent block success with a minimal hemidiaphragmatic paralysis rate, suggesting the need for further studies to confirm this result in arthroscopic shoulder surgery.
引用
- Zhang H, Wu J, Miao Y, et al. Determination of the Optimal Volume of 0.5% Ropivacaine in Single-injection Retroclavicular Brachial Plexus Block for Arthroscopic Shoulder Surgery: A Phase I/II Trial. Anesthesiology. 2025. PMID: 39018520. doi:10.1097/ALN.0000000000005159
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。